MAPK3 and breast cancer: Over-expression of PTPRG in breast cancer cells prolongs doubling times and colony sizes of breast cancer cells [15] and inhibits in vivo breast tumor formation through up-regulation of p21 and p27 by suppression of ERK1/2 [16].